Media Coverage

08
April
2022
Oxehealth among Beauhurst's Top 19 UK Health-tech Companies
11
August
2020

Oxehealth was featured in the top 19 UK healthcare companies by Beauhurst, who specialize in researching and analyzing the UK’s fastest growing companies.

08
April
2022
Oxehealth and partners get shortlisted as finalists for FOUR HSJ Partnership Awards 2021
14
December
2020

Oxehealth is delighted to announce that, with our partners; South London and Maudsley FT, Oxford Health, Coventry and Warwickshire Partnership Trust, we have been shortlisted for FOUR separate HSJ Partnership Awards!

08
April
2022
Oxehealth Featured By Healthcare UK As One Of The “First 100” Digital Health Companies
24
February
2021

We at Oxehealth are delighted to announce that we've been selected as one of the “First 100 Digital Health Companies” by Healthcare UK. The list was announced by Healthcare UK this morning.

08
April
2022
Oxehealth secures world-first accreditation for its vital signs technology
18
September
2018

The British Standards Institute (BSI) has accredited Oxehealth’s vital signs measurement software as a Class IIa medical device in Europe.

08
April
2022
FDA grants Oxehealth Vital Signs De Novo clearance; Oxehealth launches in the US
31
March
2021

Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product.